Market Executive Summary
Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood
Due to the COVID-19 pandemic, the global Non-Invasive Prenatal Testing market size was US$ 4884.4 million in 2022 and is forecast to a readjusted size of US$ 10060 million by 2029 with a CAGR of 10.7% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, High & Average Risk accounting for % of the Non-Invasive Prenatal Testing global market in 2022, is projected to value US$ million by 2029, growing at a revised ?GR from 2023 to 2029. While 0-12 Weeks segment is altered to an ?GR throughout this forecast period.
The global key companies of Non-Invasive Prenatal Testing include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Non-Invasive Prenatal Testing market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2029, trailing a CAGR of % through the analysis period. As for the Europe Non-Invasive Prenatal Testing landscape, Germany is projected to reach US$ million by 2029. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Non-Invasive Prenatal Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Non-Invasive Prenatal Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Non-Invasive Prenatal Testing market. Readers of the report can become informed about current and future trends of the global Non-Invasive Prenatal Testing market and how they will impact market growth during the forecast period.
By Company
Sequenom
Roche
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina
Berry Genomics
Segment by Type
High & Average Risk
Low Risk
Segment by Application
0-12 Weeks
13-24 Weeks
25-36 Weeks
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Non-Invasive Prenatal Testing in global and regional level.
Chapter 3: Detailed analysis of Non-Invasive Prenatal Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive Prenatal Testing revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 High & Average Risk
1.2.3 Low Risk
1.3 Market by Application
1.3.1 Global Non-Invasive Prenatal Testing Market Growth Rate by Application: 2018 VS 2022 VS 2029
1.3.2 0-12 Weeks
1.3.3 13-24 Weeks
1.3.4 25-36 Weeks
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Non-Invasive Prenatal Testing Market Size (2018-2029)
2.2 Non-Invasive Prenatal Testing Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
2.3 Global Non-Invasive Prenatal Testing Market Size by Region (2018-2023)
2.4 Global Non-Invasive Prenatal Testing Market Size Forecast by Region (2024-2029)
2.5 Global Top 10 Non-Invasive Prenatal Testing Countries Ranking by Market Size
3 Non-Invasive Prenatal Testing Competitive by Company
3.1 Global Non-Invasive Prenatal Testing Revenue by Players
3.1.1 Global Non-Invasive Prenatal Testing Revenue by Players (2018-2023)
3.1.2 Global Non-Invasive Prenatal Testing Market Share by Players (2018-2023)
3.2 Global Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Non-Invasive Prenatal Testing Revenue
3.4 Global Non-Invasive Prenatal Testing Market Concentration Ratio
3.4.1 Global Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Testing Revenue in 2022
3.5 Global Key Players of Non-Invasive Prenatal Testing Head office and Area Served
3.6 Global Key Players of Non-Invasive Prenatal Testing, Product and Application
3.7 Global Key Players of Non-Invasive Prenatal Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Non-Invasive Prenatal Testing Breakdown Data by Type
4.1 Global Non-Invasive Prenatal Testing Historic Revenue by Type (2018-2023)
4.2 Global Non-Invasive Prenatal Testing Forecasted Revenue by Type (2024-2029)
5 Global Non-Invasive Prenatal Testing Breakdown Data by Application
5.1 Global Non-Invasive Prenatal Testing Historic Market Size by Application (2018-2023)
5.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Non-Invasive Prenatal Testing Revenue by Company (2021-2023)
6.2 North America Non-Invasive Prenatal Testing Revenue by Type (2018-2029)
6.3 North America Non-Invasive Prenatal Testing Revenue by Application (2018-2029)
6.4 North America Non-Invasive Prenatal Testing Revenue by Country (2018-2029)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Non-Invasive Prenatal Testing Revenue by Company (2021-2023)
7.2 Europe Non-Invasive Prenatal Testing Revenue by Type (2018-2029)
7.3 Europe Non-Invasive Prenatal Testing Revenue by Application (2018-2029)
7.4 Europe Non-Invasive Prenatal Testing Revenue by Country (2018-2029)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Non-Invasive Prenatal Testing Revenue by Company (2021-2023)
8.2 Asia Pacific Non-Invasive Prenatal Testing Revenue by Type (2018-2029)
8.3 Asia Pacific Non-Invasive Prenatal Testing Revenue by Application (2018-2029)
8.4 Asia Pacific Non-Invasive Prenatal Testing Revenue by Region (2018-2029)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Non-Invasive Prenatal Testing Revenue by Company (2021-2023)
9.2 Latin America Non-Invasive Prenatal Testing Revenue by Type (2018-2029)
9.3 Latin America Non-Invasive Prenatal Testing Revenue by Application (2018-2029)
9.4 Latin America Non-Invasive Prenatal Testing Revenue by Country (2018-2029)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-Invasive Prenatal Testing Revenue by Company (2021-2023)
10.2 Middle East and Africa Non-Invasive Prenatal Testing Revenue by Type (2018-2029)
10.3 Middle East and Africa Non-Invasive Prenatal Testing Revenue by Application (2018-2029)
10.4 Middle East and Africa Non-Invasive Prenatal Testing Revenue by Country (2018-2029)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Sequenom
11.1.1 Sequenom Company Details
11.1.2 Sequenom Business Overview
11.1.3 Sequenom Non-Invasive Prenatal Testing Products and Services
11.1.4 Sequenom Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.1.5 Sequenom Non-Invasive Prenatal Testing SWOT Analysis
11.1.6 Sequenom Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Non-Invasive Prenatal Testing Products and Services
11.2.4 Roche Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.2.5 Roche Non-Invasive Prenatal Testing SWOT Analysis
11.2.6 Roche Recent Development
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Non-Invasive Prenatal Testing Products and Services
11.3.4 Natera Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.3.5 Natera Non-Invasive Prenatal Testing SWOT Analysis
11.3.6 Natera Recent Development
11.4 LabCorp
11.4.1 LabCorp Company Details
11.4.2 LabCorp Business Overview
11.4.3 LabCorp Non-Invasive Prenatal Testing Products and Services
11.4.4 LabCorp Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.4.5 LabCorp Non-Invasive Prenatal Testing SWOT Analysis
11.4.6 LabCorp Recent Development
11.5 BGI Genomics
11.5.1 BGI Genomics Company Details
11.5.2 BGI Genomics Business Overview
11.5.3 BGI Genomics Non-Invasive Prenatal Testing Products and Services
11.5.4 BGI Genomics Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.5.5 BGI Genomics Non-Invasive Prenatal Testing SWOT Analysis
11.5.6 BGI Genomics Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Details
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Products and Services
11.6.4 Quest Diagnostics Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.6.5 Quest Diagnostics Non-Invasive Prenatal Testing SWOT Analysis
11.6.6 Quest Diagnostics Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Non-Invasive Prenatal Testing Products and Services
11.7.4 Illumina Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.7.5 Illumina Non-Invasive Prenatal Testing SWOT Analysis
11.7.6 Illumina Recent Development
11.8 Berry Genomics
11.8.1 Berry Genomics Company Details
11.8.2 Berry Genomics Business Overview
11.8.3 Berry Genomics Non-Invasive Prenatal Testing Products and Services
11.8.4 Berry Genomics Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.8.5 Berry Genomics Non-Invasive Prenatal Testing SWOT Analysis
11.8.6 Berry Genomics Recent Development
12 Non-Invasive Prenatal Testing Market Dynamics
12.1 Non-Invasive Prenatal Testing Industry Trends
12.2 Non-Invasive Prenatal Testing Market Drivers
12.3 Non-Invasive Prenatal Testing Market Challenges
12.4 Non-Invasive Prenatal Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures
List of Tables
Table 1. Global Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of High & Average Risk
Table 3. Key Players of Low Risk
Table 4. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Non-Invasive Prenatal Testing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
Table 6. Global Non-Invasive Prenatal Testing Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Non-Invasive Prenatal Testing Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 8. Global Non-Invasive Prenatal Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Table 9. Global Non-Invasive Prenatal Testing Revenue by Players (2018-2023) & (US$ Million)
Table 10. Global Non-Invasive Prenatal Testing Market Share by Players (2018-2023)
Table 11. Global Top Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2022)
Table 12. Ranking of Global Top Non-Invasive Prenatal Testing Companies by Revenue (US$ Million) in 2022
Table 13. Global 5 Largest Players Market Share by Non-Invasive Prenatal Testing Revenue (CR5 and HHI) & (2018-2023)
Table 14. Global Key Players of Non-Invasive Prenatal Testing, Headquarters and Area Served
Table 15. Global Key Players of Non-Invasive Prenatal Testing, Product and Application
Table 16. Global Key Players of Non-Invasive Prenatal Testing, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Non-Invasive Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)
Table 19. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2018-2023)
Table 20. Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 21. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2024-2029)
Table 22. Global Non-Invasive Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Non-Invasive Prenatal Testing Revenue Market Share by Application (2018-2023)
Table 24. Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Non-Invasive Prenatal Testing Revenue Market Share by Application (2024-2029)
Table 26. North America Non-Invasive Prenatal Testing Revenue by Company (2021-2023) & (US$ Million)
Table 27. North America Non-Invasive Prenatal Testing Revenue by Type (2018-2023) & (US$ Million)
Table 28. North America Non-Invasive Prenatal Testing Revenue by Type (2024-2029) & (US$ Million)
Table 29. North America Non-Invasive Prenatal Testing Revenue by Application (2018-2023) & (US$ Million)
Table 30. North America Non-Invasive Prenatal Testing Revenue by Application (2024-2029) & (US$ Million)
Table 31. North America Non-Invasive Prenatal Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Non-Invasive Prenatal Testing Revenue by Country (2018-2023) & (US$ Million)
Table 33. North America Non-Invasive Prenatal Testing Revenue by Country (2024-2029) & (US$ Million)
Table 34. Europe Non-Invasive Prenatal Testing Revenue by Company (2021-2023) & (US$ Million)
Table 35. Europe Non-Invasive Prenatal Testing Revenue by Type (2018-2023) & (US$ Million)
Table 36. Europe Non-Invasive Prenatal Testing Revenue by Type (2024-2029) & (US$ Million)
Table 37. Europe Non-Invasive Prenatal Testing Revenue by Application (2018-2023) & (US$ Million)
Table 38. Europe Non-Invasive Prenatal Testing Revenue by Application (2024-2029) & (US$ Million)
Table 39. Europe Non-Invasive Prenatal Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Non-Invasive Prenatal Testing Revenue by Country (2018-2023) & (US$ Million)
Table 41. Europe Non-Invasive Prenatal Testing Revenue by Country (2024-2029) & (US$ Million)
Table 42. Asia Pacific Non-Invasive Prenatal Testing Revenue by Company (2021-2023) & (US$ Million)
Table 43. Asia Pacific Non-Invasive Prenatal Testing Revenue by Type (2018-2023) & (US$ Million)
Table 44. Asia Pacific Non-Invasive Prenatal Testing Revenue by Type (2024-2029) & (US$ Million)
Table 45. Asia Pacific Non-Invasive Prenatal Testing Revenue by Application (2018-2023) & (US$ Million)
Table 46. Asia Pacific Non-Invasive Prenatal Testing Revenue by Application (2024-2029) & (US$ Million)
Table 47. Asia-Pacific Non-Invasive Prenatal Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 48. Asia Pacific Non-Invasive Prenatal Testing Revenue by Region (2018-2023) & (US$ Million)
Table 49. Asia Pacific Non-Invasive Prenatal Testing Revenue by Region (2024-2029) & (US$ Million)
Table 50. Latin America Non-Invasive Prenatal Testing Revenue by Company (2021-2023) & (US$ Million)
Table 51. Latin America Non-Invasive Prenatal Testing Revenue by Type (2018-2023) & (US$ Million)
Table 52. Latin America Non-Invasive Prenatal Testing Revenue by Type (2024-2029) & (US$ Million)
Table 53. Latin America Non-Invasive Prenatal Testing Revenue by Application (2018-2023) & (US$ Million)
Table 54. Latin America Non-Invasive Prenatal Testing Revenue by Application (2024-2029) & (US$ Million)
Table 55. Latin America Non-Invasive Prenatal Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 56. Latin America Non-Invasive Prenatal Testing Revenue by Country (2018-2023) & (US$ Million)
Table 57. Latin America Non-Invasive Prenatal Testing Revenue by Country (2024-2029) & (US$ Million)
Table 58. Middle East and Africa Non-Invasive Prenatal Testing Revenue by Company (2021-2023) & (US$ Million)
Table 59. Middle East and Africa Non-Invasive Prenatal Testing Revenue by Type (2018-2023) & (US$ Million)
Table 60. Middle East and Africa Non-Invasive Prenatal Testing Revenue by Type (2024-2029) & (US$ Million)
Table 61. Middle East and Africa Non-Invasive Prenatal Testing Revenue by Application (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Non-Invasive Prenatal Testing Revenue by Application (2024-2029) & (US$ Million)
Table 63. Middle East and Africa Non-Invasive Prenatal Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East and Africa Non-Invasive Prenatal Testing Revenue by Country (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Non-Invasive Prenatal Testing Revenue by Country (2024-2029) & (US$ Million)
Table 66. Sequenom Company Details
Table 67. Sequenom Business Overview
Table 68. Sequenom Non-Invasive Prenatal Testing Product and Services
Table 69. Sequenom Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
Table 70. Sequenom Non-Invasive Prenatal Testing SWOT Analysis
Table 71. Sequenom Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Non-Invasive Prenatal Testing Product and Services
Table 75. Roche Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
Table 76. Roche Non-Invasive Prenatal Testing SWOT Analysis
Table 77. Roche Recent Development
Table 78. Natera Company Details
Table 79. Natera Business Overview
Table 80. Natera Non-Invasive Prenatal Testing Product and Services
Table 81. Natera Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
Table 82. Natera Non-Invasive Prenatal Testing SWOT Analysis
Table 83. Natera Recent Development
Table 84. LabCorp Company Details
Table 85. LabCorp Business Overview
Table 86. LabCorp Non-Invasive Prenatal Testing Product and Services
Table 87. LabCorp Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
Table 88. LabCorp Non-Invasive Prenatal Testing SWOT Analysis
Table 89. LabCorp Recent Development
Table 90. BGI Genomics Company Details
Table 91. BGI Genomics Business Overview
Table 92. BGI Genomics Non-Invasive Prenatal Testing Product and Services
Table 93. BGI Genomics Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
Table 94. BGI Genomics Non-Invasive Prenatal Testing SWOT Analysis
Table 95. BGI Genomics Recent Development
Table 96. Quest Diagnostics Company Details
Table 97. Quest Diagnostics Business Overview
Table 98. Quest Diagnostics Non-Invasive Prenatal Testing Product and Services
Table 99. Quest Diagnostics Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
Table 100. Quest Diagnostics Non-Invasive Prenatal Testing SWOT Analysis
Table 101. Quest Diagnostics Recent Development
Table 102. Illumina Company Details
Table 103. Illumina Business Overview
Table 104. Illumina Non-Invasive Prenatal Testing Product and Services
Table 105. Illumina Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
Table 106. Illumina Non-Invasive Prenatal Testing SWOT Analysis
Table 107. Illumina Recent Development
Table 108. Berry Genomics Company Details
Table 109. Berry Genomics Business Overview
Table 110. Berry Genomics Non-Invasive Prenatal Testing Product and Services
Table 111. Berry Genomics Non-Invasive Prenatal Testing Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
Table 112. Berry Genomics Non-Invasive Prenatal Testing SWOT Analysis
Table 113. Berry Genomics Recent Development
Table 114. Non-Invasive Prenatal Testing Market Trends
Table 115. Non-Invasive Prenatal Testing Market Drivers
Table 116. Non-Invasive Prenatal Testing Market Challenges
Table 117. Non-Invasive Prenatal Testing Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Invasive Prenatal Testing Product Picture
Figure 2. Global Non-Invasive Prenatal Testing Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
Figure 3. Global Non-Invasive Prenatal Testing Market Share by Type: 2022 VS 2029
Figure 4. High & Average Risk Features
Figure 5. Low Risk Features
Figure 6. Global Non-Invasive Prenatal Testing Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
Figure 7. Global Non-Invasive Prenatal Testing Market Share by Application: 2022 VS 2029
Figure 8. 0-12 Weeks
Figure 9. 13-24 Weeks
Figure 10. 25-36 Weeks
Figure 11. Non-Invasive Prenatal Testing Report Years Considered
Figure 12. Global Non-Invasive Prenatal Testing Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Non-Invasive Prenatal Testing Market Size 2018-2029 (US$ Million)
Figure 14. Global Non-Invasive Prenatal Testing Market Size Market Share by Region: 2022 VS 2029
Figure 15. Global Non-Invasive Prenatal Testing Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global Non-Invasive Prenatal Testing Revenue Market Share Forecast by Region (2024-2029)
Figure 17. Global Top 10 Non-Invasive Prenatal Testing Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global Non-Invasive Prenatal Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Figure 19. Global Non-Invasive Prenatal Testing Market Share by Players in 2022
Figure 20. Global Top Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Non-Invasive Prenatal Testing Revenue in 2022
Figure 22. North America Non-Invasive Prenatal Testing Revenue Market Share by Company in 2022
Figure 23. North America Non-Invasive Prenatal Testing Revenue Market Share by Type (2018-2029)
Figure 24. North America Non-Invasive Prenatal Testing Revenue Market Share by Application (2018-2029)
Figure 25. North America Non-Invasive Prenatal Testing Revenue Share by Country (2018-2029)
Figure 26. U.S. Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 27. Canada Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 28. Europe Non-Invasive Prenatal Testing Revenue Market Share by Company in 2022
Figure 29. Europe Non-Invasive Prenatal Testing Revenue Market Share by Type (2018-2029)
Figure 30. Europe Non-Invasive Prenatal Testing Revenue Market Share by Application (2018-2029)
Figure 31. Europe Non-Invasive Prenatal Testing Revenue Share by Country (2018-2029)
Figure 32. Germany Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 33. France Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 34. U.K. Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 35. Italy Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 36. Russia Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Non-Invasive Prenatal Testing Revenue Market Share by Company in 2022
Figure 38. Asia Pacific Non-Invasive Prenatal Testing Revenue Market Share by Type (2018-2029)
Figure 39. Asia Pacific Non-Invasive Prenatal Testing Revenue Market Share by Application (2018-2029)
Figure 40. Asia Pacific Non-Invasive Prenatal Testing Revenue Share by Region (2018-2029)
Figure 41. China Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 42. Japan Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 43. South Korea Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 44. India Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 45. Australia Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 46. Taiwan Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 47. Indonesia Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 48. Thailand Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 49. Malaysia Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 50. Philippines Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 51. Vietnam Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 52. Latin America Non-Invasive Prenatal Testing Revenue Market Share by Company in 2022
Figure 53. Latin America Non-Invasive Prenatal Testing Revenue Market Share by Type (2018-2029)
Figure 54. Latin America Non-Invasive Prenatal Testing Revenue Market Share by Application (2018-2029)
Figure 55. Latin America Non-Invasive Prenatal Testing Revenue Share by Country (2018-2029)
Figure 56. Mexico Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 57. Brazil Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 58. Argentina Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 59. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Company in 2022
Figure 60. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Non-Invasive Prenatal Testing Revenue Share by Country (2018-2029)
Figure 63. Turkey Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 64. Saudi Arabia Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 65. UAE Non-Invasive Prenatal Testing Revenue (2018-2029) & (US$ Million)
Figure 66. Sequenom Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
Figure 67. Roche Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
Figure 68. Natera Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
Figure 69. LabCorp Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
Figure 70. BGI Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
Figure 71. Quest Diagnostics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
Figure 72. Illumina Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
Figure 73. Berry Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
